In response to the declaration of global pandemic of Coronavirus infectious disease 2019 (COVID-19) caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we provide comprehensive content on Coronavirus molecular structures and its interactions:

Search

SARS-CoV-2 spike Protein TM domain
Authors
Fu, Q., Chou, J.J.
Assembly
Spike glycoprotein
Entity
1. Spike glycoprotein (polymer, Thiol state: not present), 21 monomers, 2200.701 × 3 Da Detail

WLGFIAGLIA IVLVTILLSS T


Total weight
6602.1025 Da
Max. entity weight
2200.701 Da
Source organism
Severe acute respiratory syndrome coronavirus 2
Exptl. method
solution NMR
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 100.0 %, Completeness: 32.9 %, Completeness (bb): 64.3 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All32.9 % (81 of 246)16.7 % (20 of 120)39.4 % (41 of 104)90.9 % (20 of 22)
Backbone64.3 % (81 of 126)45.5 % (20 of 44)67.2 % (41 of 61)95.2 % (20 of 21)
Sidechain 0.0 % (0 of 139) 0.0 % (0 of 76) 0.0 % (0 of 62) 0.0 % (0 of 1)
Aromatic 0.0 % (0 of 22) 0.0 % (0 of 11) 0.0 % (0 of 10) 0.0 % (0 of 1)
Methyl 0.0 % (0 of 52) 0.0 % (0 of 26) 0.0 % (0 of 26)

1. entity 1

WLGFIAGLIA IVLVTILLSS T

Sample #1

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303 K, pH 6.8, Details 55 mM [U-99% 2H] 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine, 100 mM [U-99% 2H] 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine, 20 mM TRIS, 0.02 % sodium azide, 20 mM sodium chloride, 1 mM [U-13C; U-15N] Spike glycoprotein, 90% H2O/10% D2O


#NameIsotope labelingTypeConcentration
11,2-dimyristoyl-sn-Glycero-3-Phosphocholine[U-99% 2H]55 mM
21,2-dihexanoyl-sn-Glycero-3-Phosphocholine[U-99% 2H]100 mM
3TRISnatural abundance20 mM
4sodium azidenatural abundance0.02 %
5sodium chloridenatural abundance20 mM
6Spike glycoprotein[U-13C; U-15N]1 mM
Sample #2

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303 K, pH 6.8, Details 55 mM [U-99% 2H] 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine, 100 mM [U-99% 2H] 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine, 20 mM TRIS, 0.02 % sodium azide, 20 mM sodium chloride, 1 mM [U-13C; U-15N; U-2H] Spike glycoprotein, 90% H2O/10% D2O


#NameIsotope labelingTypeConcentration
71,2-dimyristoyl-sn-Glycero-3-Phosphocholine[U-99% 2H]55 mM
81,2-dihexanoyl-sn-Glycero-3-Phosphocholine[U-99% 2H]100 mM
9TRISnatural abundance20 mM
10sodium azidenatural abundance0.02 %
11sodium chloridenatural abundance20 mM
12Spike glycoprotein[U-13C; U-15N; U-2H]1 mM
Sample #3

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303 K, pH 6.8, Details 55 mM 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine, 100 mM 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine, 20 mM TRIS, 0.02 % sodium azide, 20 mM sodium chloride, 1 mM [U-15N; U-2H] Spike glycoprotein, 90% H2O/10% D2O


#NameIsotope labelingTypeConcentration
131,2-dimyristoyl-sn-Glycero-3-Phosphocholinenatural abundance55 mM
141,2-dihexanoyl-sn-Glycero-3-Phosphocholinenatural abundance100 mM
15TRISnatural abundance20 mM
16sodium azidenatural abundance0.02 %
17sodium chloridenatural abundance20 mM
18Spike glycoprotein[U-15N; U-2H]1 mM
Sample #4

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 303 K, pH 6.8, Details 55 mM 1,2-dimyristoyl-sn-Glycero-3-Phosphocholine, 100 mM 1,2-dihexanoyl-sn-Glycero-3-Phosphocholine, 20 mM TRIS, 0.02 % sodium azide, 20 mM sodium chloride, 1 mM [U-13C; U-15N; U-2H] Spike glycoprotein, 90% H2O/10% D2O


#NameIsotope labelingTypeConcentration
191,2-dimyristoyl-sn-Glycero-3-Phosphocholinenatural abundance55 mM
201,2-dihexanoyl-sn-Glycero-3-Phosphocholinenatural abundance100 mM
21TRISnatural abundance20 mM
22sodium azidenatural abundance0.02 %
23sodium chloridenatural abundance20 mM
24Spike glycoprotein[U-13C; U-15N; U-2H]1 mM

Release date
2021-02-04
Citation
A Trimeric Hydrophobic Zipper Mediates the Intramembrane Assembly of SARS-CoV-2 Spike
Fu, Q., Chou, J.J.
J. Am. Chem. Soc. (2021), 143, 8543-8546, PubMed 34086443 , DOI 10.1021/jacs.1c02394 ,
Related entities 1. Spike glycoprotein, : 1 : 107 entities Detail
Experiments performed 6 experiments Detail
Chemical shift validation 3 contents Detail
Keywords COVID 19, Coronavirus, SARS, Severe acute respiratory syndrome coronavirus 2, VIRAL PROTEIN